GENEREAD
DEAD

Serial Number

85841128

Owner

QIAGEN GMBH

Attorney

G MATHEW LOMBARD

Filing Date

Feb 5, 2013

Add to watchlist:

No watchlists yet
View on USPTO

GENEREAD Trademark

Serial Number: 85841128

GENEREAD is a trademark filed by QIAGEN GMBH on February 5, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

February 5, 2013

Registration Date

Not Registered

Goods & Services

Scientific apparatuses, instruments and devices and their structural parts and components therefor for analyzing and sequencing biomolecules, namely, nucleic acids; computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids; scientific apparatuses, instruments and devices for analysis of nucleic acids, namely, nucleic acid sequencers

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical reagents, enzymes and buffer solutions for scientific and medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 19, 2014 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 19, 2014 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2013 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2013 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2013 CRFA
ASSIGNED TO LIE
Sep 24, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2013 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2013 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Feb 12, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2013 NWOS
NEW APPLICATION ENTERED
Feb 8, 2013 NWAP